Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2021-03-26 2021-01-18
Drug Identification Number 02041421 02041421
Brand name ATIVAN ATIVAN
Common or Proper name ATIVAN 1MG ATIVAN 1MG
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000's 1000's
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-18 2021-01-18
Estimated end date 2021-04-12 2021-04-12
Actual end date 2021-03-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Available inventory is currently on preventative allocation. Available inventory is currently on preventative allocation.
Health Canada comments